Received May 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV4 | HPV (GARDASIL) | MERCK & CO. INC. | UNK | — | OT |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | OT |
Grandmother of patient reporting that patient began having seizures after having GARDASIL administered. She is not sure if it was GARDASIL or GARASIL 9. She says it was administered a year or two ago. She does not have any additional information and; This spontaneous report was received from the patient's grandmother and refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. In approximately 2023, reported as "a year or two ago", the patient was vaccinated with the company unidentified Human Papillomavirus (HPV) vaccine (name and lot number not provided), administered by Unknown route (reported as "Injection") for the indication "vaccine". On an unknown date, after having the vaccine, the patient began having seizures. The reporter did not have any additional. At the reporting time, the outcome of seizures was unknown. The causal relationship between the event the company unidentified Human Papillomavirus (HPV) vaccine was not reported. Upon internal review, the event of seizure was determined to be medically significant. Additional information is not expected.